Autism & I/DD

Intellectual and developmental disabilities (I/DD) are a physical and/or cognitive impairments that occur before the age of 22. Autism spectrum disorder is generally considered a type of developmental disability that affects behaviour and communication. The autism and I/DD market provides supports and health care services to these populations. Over the past decade, there has been an increase in the changes and challenges affecting I/DD and autism markets—the move to managed care and value-based care, the shift away from residential treatment, the increasing emphasis on consumer-directed care, and new workforce challenges.

Latest Resources

• Northeast Arc To Offer Telehealth Services In Residential Homes
• Oklahoma Reduces Developmental Disabilities Services Wait Time From 13 Years Down To One Year
• Nebraska Reduces I/DD Waiting List By 75%, From 2,700 In 2024 To 700 In 2025
• Nebraska DDD Home & Community-Based Services Waiver Transformation: ‘Access For All’
• Nebraska Division of Developmental Disabilities Fiscal Year 2024 Annual Report For July 1, 2023–June 30, 2024
• Delaware Issues RFP To Continue Building Its HCBS Capacity For Individuals With Intellectual/Developmental Disabilities
• Delaware Division Of Developmental Disabilities Services Application For 1915(c) HCBS Waiver, Approved July 1, 2024
• 79% Of Americans Want To Know Early If They Have Alzheimer’s Disease
• NexPhase Capital Acquires Behavior Frontiers From Lorient Capital
• Trillium Health Resources & North Carolina Partner With Attend Behavior To Provide Virtual Support For Families Of Children With Behavioral Disabilities
• Intermountain Primary Children’s Hospital Opens New Autism Clinic In Riverton, Utah
• COR Behavioral Group & Baker Street Behavioral Health Open Pediatric Development Center In Flemington, New Jersey
• Dementia Costs The U.S. $781 Billion In 2025: 30% Is For Medical & Long-Term Care
• New York Selects Eight Organizations For I/DD In-Home Assistive Technology
• Telehealth, Social & Chronic Specialties Featured In Fierce Healthcare’s ‘Fierce 15’ Of 2025

See All

About 42% Of Children With Neurodevelopmental Disorders Have Rare Genetic Conditions

Genetic testing for a group of 246 children with neurodevelopmental disorders (NDDs) such as autism, developmental delay, and other neurodevelopmental disorders revealed that 41.8% had rare genetic mutations that would benefit from changes in clinical management. The genetic testing focused on identifying genetic mutations (also called pathogenic variants) that increase the risk of developing a disease or disorder. Within this group, there were 62 different genetic diagnoses. The majority, 50 diagnoses, were found in just… Read

• Arizona Division Of Developmental Disabilities To Implement Cost-Cutting Strategies
• New York To Expand Home-Based Crisis Intervention Pilot For Youth With I/DD & Co-Occurring Mental Health Disorders
• Moving From Red To Black
• Lighthouse Autism Center Expands Diagnostic Testing Services To Shorten Wait Times & Increase Access To Care
• Autism Rates Continue To Rise In The U.S., Affecting 3.2% Of Eight-Year-Olds In 2022

To sign-up for monthly Autism & I/DD Services alerts, you must be signed in to your account.